Cell 2026
November 2026
, UK
, UK
.png "Live Now Button (3)")
Bo Wiinberg
Chief Business Development Officer,
Novo Nordisk Foundation
Daria Marsh
Head of Bioprocessing,
Cell and Gene Therapy Catapult
Debesh Mandal
Co-Founder & Chief Executive Officer,
Nanograb
François Gianelli
Chief Regulatory & Quality Officer,
TreeFrog Therapeutics
Joanna Brewer
Former Chief Scientific Officer,
Adaptimmune
Kerry Sieger
Vice President of Global Quality Operations,
Immatics
Liz Ramsburg
Head of Research,
Roche Innovation Center Philadelphia
Peter Andersen
Chief Research & Development Officer,
TreeFrog Therapeutics
Terri Gaskell
Chief Technology Officer,
Rinri Therapeutics
Thorsten Gorba
Vice President Process & Analytical Development,
Aspen Neuroscience
Aline Miller
Professor,
University of Manchester
Arindam Mitra
Director of CMC,
Leucid Bio
Ayca Cetinkaya
Senior Scientist,
AstraZeneca
Bart Royens
Senior Scientist,
MSAT USP, Sanofi
Ben Weil
Chief Operating Officer & Chief Manufacturing Officer,
INmune Bio
Bobby Gaspar
Co-Founder & Chief Executive Officer,
Orchard Therapeutics
Chiara Recchi
Director, Research & Discovery,
Orchard Therapeutics
Christof Von Kalle
Director, BIH & Charité Clinical Study Center BIH Chair for Clinical and Translational Sciences Director,
Research Clinic Luxemburg
Claire Kerridge
Head of Gene Therapy,
Medicines and Healthcare products Regulatory Agency
Claire Irvine
European and UK Patent Attorney Of Counsel,
Beck Greener
Clare Selden
Professor of Experimental Hepatology,
University College London
Cornel Chiriac
Investment Director,
M&G Investments
Cristina Peixoto
Head Of Downstream Process Development Lab & Coordinator Of Bioproduction Unit,
iBET
David Roig-Carles
Principal Scientist Process Development,
Adaptimmune
Diana Hernandez
Director of Immune and Advanced Therapies,
Anthony Nolan
Duygu Dikicioglu
Associate Professor,
University College London
Edwige Gros
Senior Principal Scientist,
Amgen
Ermir Kalaj
Chief Executive Officer,
Cellula Therapeutics
Frank Staal
Professor of Stem Cell Biology,
Leiden University Medical Center
Gemma Everitt
Senior Research Scientist, UK Cell Culture & Banking,
AstraZeneca
Giacomo Domenici
Research Scientist,
iBET
Huaiyu Yang
Senior Lecturer,
Loughborough University
Ibon Garitaonandia
Chief Scientific Officer,
CellProthera
James Matthews
Senior Scientist,
Purespring Therapeutics
Jas Uppal
Senior Vice President, Head of Regulatory,
BlueRock Therapeutics
Jessica Whelan
Lecturer,
University College Dublin
Joe Betts-LaCroix
Chief Executive Officer,
Retro Biosciences
Jon Beaman
Deputy Director Innovative Medicines ,
MHRA
Joshua Bagley
Chief Scientific Officer,
a:head bio
Julie Beaudet
Chemistry, Manufacturing and Control Senior Staff Scientist,
Regeneron
Julien Fleurence
Discovery Safety Specialist,
AstraZeneca
Katy Trost
Chief Executive Officer Coach & Advisor/Founder,
Pera CEO Network
Keith Wong
Associate Director of Process Development,,
Autolus
Kenny Dalgarno
Professor,
Newcastle University
Kiran Moyo
National Senior Manager ,
NHSengland
Kristian Tryggvason
Co-Founder, Chief Executive Officer,
Alder Therapeutics
Leila Abbas
Preclinical Lead,
Rinri Therapeutics
Lilian Hook
Director Cell, Apheresis and Gene Therapies,
NHS Blood and Transplant
Lindsay Davies
Chief Scientific Officer,
NextCell Pharma
.jpg?length=600&name=0720636c-7a84-4074-8509-6a67a83f1b35-2-11764368speaker_photo-Bluu-Foto-Linn-(2).jpg)
Linn Marie Kreins
Scientist,
Bluu GmbH
Lucy Williams
Partner, European & UK Patent Attorney,
J A Kemp
Mali Eskandarpour
Senior Research Fellow,
University College London
Márcia Mata
Programme Head of Automation,
Cell And Gene Therapy Catapult
Maria Barreira Gonzalez
Programme Head of Gene Modification,
Cell and Gene Therapy Catapult
Marina Tarunina
Research Director,
Plasticell
Martin Bornhäuser
Professor,
King’s College London
Maryna Panamarova
3D Cellular Modelling Specialist, Cellular Operations,
Wellcome Sanger Institute
Matt Stone
Director of Supply Chain,
REGENXBIO
Mitchell Braam
Scientist,
Cell and Gene Therapy Catapult
Molly Stevens
John Black Professor of Bionanoscience,
University of Oxford
Nicole Lund
Senior Quality Control Director,
BlueRock Therapeutics
Nitin Patel
Vice President of Late-Stage Clinical Development,
Legend Biotech
Panteli Theocharous
Chairman of the Board of Directors, TMOIF & Chief Executive Officer,
VectorGen
Pauline Lestringant
Director Regulatory Science,
Voisin Consulting Life Sciences
Rachel Haines
Vice President, Clinical Development & Operations,
Rinri Therapeutics
Rhiannon David
Senior Director, Head of Advanced Cell Models, Safety Sciences,
AstraZeneca
.jpg?length=600&name=9b9bfd39-4456-4616-9f1e-7d162c375fa2-2-11764368speaker_photo-Richard-head-shot-2-(1).jpg)
Richard Forsey
Project Specialist,
NHS Blood and Transplant
Robert Zweigerdt
Professor & Principal Investigator,
Hannover Medical School
Roelof Rongen
Chief Executive Officer,
AeirBio
Ruth Faram
Co-Founder & Chief Scientific Officer,
SymphoRNA
Sabina Lancaster
Technical Programme Head,
Legend Bio
sanjeev Luther
CEO,
Ernexa
Sara Ramos
Senior Investigator-Cell Sciences,
IG Innovation
Sarah McAleer
Pharmacy Lead Innovative Treatments,
NHS England
Sarah Snykers
Senior Director Operations,
Legend Biotech
Sujith Sebastian
Viral Vector Hub Manager,
NHS Blood and Transplant
Sven Kili
Partner,
Saisei Ventures
Taisiia Mukii
Founding Ambassador,
Women in STEM Network
Tamara Straub
Senior Scientist,
Boehringer Ingelheim
Tatyana Ponomaryov
Principal Scientist,
Plasticell
Thijs Gerritzen
Director CMC Development,
Amarna Therapeutics
Tiffany Rau
Professor Biochemistry & Cell Biology,
University College Cork
Ulrich Rümenapp
Senior Biotech Program Lead,
Bayer
Vasiliki kalodimou
Dr,
EUC Frankfurt Branch Medical University
Vincenzo Di Cerbo
Programme Head of Digital Innovation,
Cell and Gene Therapy Catapult
Sponsors of Cell 2025
Diamond Sponsor
Sartorius Stedim Biotech GmbH
Diamond Sponsor
Simplifying Progress
We are living in the bio-century. Global medical knowledge is expanding at a rapid pace. But despite huge breakthroughs, many diseases, such as cancer, rheumatism or Alzheimer's, are still not curable.
Sartorius is part of the solution. We help to ensure that new scientific discoveries can be translated more quickly into effective patient care. With technologies, platforms and partnerships for a common goal: better health for more people.
Platinum Sponsors
Thermo Fisher
Platinum Sponsor
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
For more information, please visit www.thermofisher.com
Gold Sponsors
10x Genomics
Gold Sponsor
10x Genomics was founded on the vision that this century will bring advances in biomedicine and transform the way we understand and treat disease. We deliver powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Our end-to-end single cell and spatial solutions include instruments, consumables, and intuitive software, letting you unravel highly intricate biological systems, while bringing into focus the details that matter most.
Acro Biosystems
Gold Sponsor
ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Our mission is to help overcome challenges with innovative tools and solutions from discovery to the clinic. We supply life science tools designed for discovery research and scalable to the clinical phase and beyond. By consistently adapting to new regulatory challenges and guidelines, we deliver solutions, whether it comes through recombinant proteins, antibodies, assay kits, GMP-grade reagents, or custom services. We empower scientists and engineers dedicated to innovation to simplify and accelerate the development of new, better, and more affordable medicine.
Beckman Coulter
Gold Sponsor
At Beckman Coulter, we're dedicated to advancing and optimizing the laboratory. For more than 80 years, we've been a trusted partner for laboratory professionals, helping advance scientific research.
We have a vital role: our focus innovation, reliability and efficiency, we've become the partner of choice for clinical and research customers around the globe.
Our solutions include automated liquid handling workstations—Biomek and Echo Acoustic Liquid Handlers—for workflows such as assay development, compound management, high-throughput screening, NGS library prep, and synthetic biology. We also offer centrifuges, cell viability analyzers, flow cytometers, and genomic reagents for DNA/RNA isolation, cleanup and size selection.
Fluidic Sciences
Gold Sponsor
Sphere Bio is a brand of Fluidic Sciences. Its technology develops and manufactures single‑cell analysis and monoclonality assurance systems that enable researchers to find, analyze, and isolate the most valuable cells with speed and precision. Its proprietary picodroplet microfluidics and Cyto‑Mine® Chroma multiplexing platform power applications across antibody discovery, cell line development, cell engineering, and cell therapy.
Fluidic Sciences develops transformative in‑solution technologies for protein interaction analysis. Its flagship Fluidity One‑M instrument leverages Microfluidic Diffusional Sizing (MDS) to measure binding affinity, stoichiometry, size, and concentration without immobilization—directly in complex backgrounds such as serum, plasma, and lysate.
GenScript
Gold Sponsor
GenScript Biotech is a world leading technology and service provider of life science R&D and manufacturing, founded in 2002 as one of the first commercialize gene synthesis providers. GenScript provides life sciences services and products to scientists in over 200 countries worldwide, including gene and gene fragments synthesis, DNA/RNA/NGS/qPRC/tRNA, & siRNA oligos, mRNA & circular RNA synthesis, custom peptide synthesis, complex protein expression and engineering, custom antibody development and engineering, in vitro/in vivo pharmacology, as well as a variety of other research-focused catalogue products. After two decades of rapid growth, the company has expanded its business in recent years into the fields of immunotherapy and early-phase drug discovery services, CDMO and microbiology. Driven by the corporate mission of “make people and nature healthier through biotechnology”, GenScript strives to become the most trustworthy biotech company in the world. GenScript offers global support for its loyal customers with dedicated sites in the Netherlands and the UK and a strong global remote workforce.
Nova Biomedical
Gold Sponsor
We’re excited to be attending Cell UK 2025. Let’s connect!
At Advanced Instruments, now proudly part of Nova Biomedical, we’re entering a new chapter - combining powerful technologies to support your bioprocessing workflows from start to finish.
Our Solentim® Cell Line Development (CLD) solutions remain at the core of our offering for biotherapeutic developers. With industry-leading technology for single-cell deposition, high-resolution imaging, and smart clone selection, we help accelerate timelines and reduce risk in CLD workflows.
But our support doesn’t stop there. We also offer tools that ensure data quality and process reliability across the lab:
* OsmoTECH®: Bioprocessing osmometers for process development and QC * FLEX2: Cell culture analyzers for efficient process monitoring * Artel: Volume verification for pipettes and liquid handlers
We would love to meet during the event to explore how our solutions can support your CLD and bioprocessing goals.
Learn more about the merger: https://www.aicompanies.com/nova-merger/
At Advanced Instruments, now proudly part of Nova Biomedical, we’re entering a new chapter - combining powerful technologies to support your bioprocessing workflows from start to finish.
Our Solentim® Cell Line Development (CLD) solutions remain at the core of our offering for biotherapeutic developers. With industry-leading technology for single-cell deposition, high-resolution imaging, and smart clone selection, we help accelerate timelines and reduce risk in CLD workflows.
But our support doesn’t stop there. We also offer tools that ensure data quality and process reliability across the lab:
* OsmoTECH®: Bioprocessing osmometers for process development and QC * FLEX2: Cell culture analyzers for efficient process monitoring * Artel: Volume verification for pipettes and liquid handlers
We would love to meet during the event to explore how our solutions can support your CLD and bioprocessing goals.
Learn more about the merger: https://www.aicompanies.com/nova-merger/
Silver Sponsors
Air Products
Silver Sponsor
Air Products Biomedical, specialises in cryogenic storage solutions and medical gases for healthcare, research, and the life sciences sector. We offer MDR-certified liquid nitrogen for applications involving human samples, such as IVF, blood banking, and transplants. Our portfolio includes high-efficiency cryogenic freezers, vapour-phase storage systems, and integrated safety and compliance solutions tailored to UK and EU regulations. We are recognised for our commitment to sustainability, sample security, and operational safety.
Aseptic Technologies
Silver Sponsor
Aseptic Technologies, part of the SKAN Group, is a global leader in aseptic processing and clean manufacturing solutions for the pharma and biotech industries.
We specialize in advanced fill & finish systems, isolator technologies, and custom single-use assemblies, supported by in-house clean injection molding in ISO-certified environments. From early development to commercial production, we deliver integrated, ready-to-use solutions that ensure sterility, compliance, and process efficiency across a wide range of drug products and ATMPs.
.png?length=600&name=55b8d348-c564-4ef9-ba33-f793f95a3c62-2-5668375logo-bm-logo-circle-rgb-(1).png){kind=logo}
BioMerieux
Silver Sponsor
To protect patients, provide safe products and minimise vein to vein time, cellular therapies sites need state-of-the-art quality control solutions.
bioMérieux’s portfolio of microbiology testing solutions enable sites to perform testing at each stage of production. bioMérieux solutions are adapted for the unique set of requirements for testing C> products. Helping to maintain regulatory compliance and optimise operations for the future.
BACT/ALERT 3D DUAL T: Compendial, rapid and automated sterility testing.
BIOFIRE MYCOPLASMA: Results in 1 hour test
ENDOZYME II GO: LAL-free endotoxin test, just add water and your sample
3P Solutions: for environmental monitoring, 3P SMART plates, 3P Connect and 3P Enterprise
Biothrust
Silver Sponsor
We are a bioreactor startup based in Germany that elevates (sensitive) cell cultivation to unmet efficiency. Our bionic bioreactor, the ComfyCell, employs an artificial lung in a STR design, providing stress-free cultivation conditions to achieve higher cell concentrations and superb quality. Through our patented Membrane Stirrer, we facilitate efficient bubble-free gas exchange for any process. The formation of foam is completely avoided while gas transfer rates are 30x what conventional bioreactors offer. This allows you to cultivate at least 258 million cells per mL with minimal risk and maximum efficiency. By efficiently scaling the cell cultivation process to more than 200L, we help provide affordable cell & gene therapies as well as driving progress in other sectors like cultured meat and synthetic biologics. We are a spin-off from the RWTH Aachen, on a mission to make novel therapies accessible for everyone.
CELLforCURE by SEQENS
Silver Sponsor
CELLforCURE by SEQENS, based near Paris, is a leader in the manufacturing of Advanced Therapy Medicinal Products (ATMPs), specialized in both autologous and allogeneic cell and gene therapy solutions. With over a decade of expertise, we provide comprehensive end-to-end services, from Phase I to full-scale commercial production.
Our cutting-edge “one-stop-shop” facility spans 10,000 sqm, including 2,200 sqm of GMP-certified production areas and 7 independent manufacturing lines, each equipped with 8 cleanrooms, ensuring maximum safety and compliance for every product.
As a trusted comprehensive solution provider, we facilitate seamless project development, leveraging in-house Quality Control for 90% of processes to deliver drug products.
With a unique blend of CDMO heritage and proven commercial manufacturing expertise, CELLforCURE is the ideal partner to help bring your innovative therapies to life, transforming groundbreaking ideas into commercial success.
Cojourney
Silver Sponsor
CoJourney is a leading CDMO specializing in developing and manufacturing advanced cell and gene therapy products. We provide end-to-end solutions, from process development to clinical and commercial-scale production of plasmids, viral vectors, mRNA, and sgRNA.
Our proprietary Zero-Chrom Platform® revolutionizes plasmid production by eliminating column chromatography, ensuring 90–95% purity, reducing contamination risks, and improving recovery rates. This innovation enhances efficiency, cutting costs by 70% and production time by 60%, while boosting AAV titers across all serotypes.
With a state-of-the-art facility in Hangzhou, China, and a process development center in Philadelphia, PA, CoJourney has supported 40+ clients, including six in Phase I & II clinical trials. Additionally, we have partnered with Azenta to establish a GMP-grade sgRNA manufacturing platform, further strengthening our capabilities in gene therapy manufacturing.
For further info, please visit www.cojourney.com
Minaris Advanced Therapies
Silver Sponsor
Minaris Advanced Therapies is a global contract development and manufacturing organization with a focus on cell and gene therapies and a contract testing provider. Minaris Advanced Therapies is headquartered in Philadelphia, Pennsylvania, and has more than 600,000 square feet of infrastructure across the United States, Europe and Asia. The organization has manufactured over 7,500 GMP batches and has a global network that supports therapy developers through early-stage development, clinical trials and commercial manufacturing. Visit www.minaris.com.
.jpg?length=600&name=74dfee8e-75c7-46e0-9f51-31b709af2ede-2-5668375logo-Nanion_logo_black_RGB_300dpi-(2).jpg){kind=logo}
Nanion Technologies GmbH
Silver Sponsor
For more than 20 years, Nanion Technologies has combined exceptional instrumentation with trusted scientific support, to accelerate successful drug development and scientific discoveries.
From studying the biophysical properties and pharmacological profile of ion channels and transporters in native and reconstituted membranes to understanding the effect of their modulation on cell proliferation, viability and function, our state-of-the-art instrumentation has revolutionized drug discovery, lead optimisation and safety assessment.
Our newest technology, AtlaZ, for high-throughput impedance spectroscopy, enables simultaneous, label-free and time resolved monitoring of diverse cellular responses. With the capability to track live cells in scalable throughput (6x 96-well plate configuration), AtlaZ operates across a range of frequencies (0.1 KHz – 100 KHz), unveiling nuanced information about cell confluence, proliferation and cytotoxicity, cancer immunotherapy as well as formation of tight junctions in epithelial and endothelial cell lines. Our user-oriented interface provides real-time and automated data analysis, final figures and plots can easily be exported together with raw data when further analysis is requested.
Applications include: Cell Proliferation, Cytotoxicity, Immune Cell-Mediated Cytotoxicity, Cancer Immunotherapy, Immuno-Oncology, Oncolytic Viruses, Receptor-mediated Signalling.
Bronze Sponsors
Bio-Rad Laboratories
Bronze Sponsor
Bio-Rad is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for 70 years, our products advance the discovery process and improve healthcare. Our customers include university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality.
BPES/SYNENTEC
Bronze Sponsor
BPES are delighted to showcase SYNENTEC at CELL 2025.
SYNENTEC GmbH is a leading provider of high-performance automated imaging and laboratory automation systems, delivering state-of-the-art hardware and software solutions for cell biology, drug discovery, stem cell research, cancer biology and vaccine development.
Their offerings include the CELLAVISTA, NYONE, myrImager, and robotic automation platform SYBOT X-1000, supported by the YT-SOFTWARE ecosystem to enable high throughput, consistent and intelligent workflows.
With 20 years of experience in high-performance imaging, SYNENTEC combines precision engineering, advanced software and automation to accelerate R&D and enable more robust, high-throughput cellular assays.
Eppendorf
Bronze Sponsor
Eppendorf - You have a vision. We have a mission.
At Eppendorf, our aim is to empower you on your upstream bioprocess journey. We provide trusted and innovative bioprocess solutions to develop cell culture and fermentation bioprocesses and move them from R&D to production. We have orchestrated our scalable bioprocess systems, single-use bioreactors, software solutions, and services to optimize process control, automate routine tasks, and harness the power of data. We listen to your specific challenges and work together with you to solve them. The bottom line is more speed, less risk, and more success in your business.
Our purpose is to help bring life-saving treatments to the world. With our bioprocess solutions and in line with our corporate mission, we contribute to the efforts of Eppendorf customers worldwide to improve human living conditions.
Since 1945, the Eppendorf Group has been headquartered in Hamburg, Germany, and today operates production and R&D sites in Europe, Asia and North America and has subsidiaries in 33 countries. Today, the Group employs more than 5,000 people worldwide.
Hamilton Company
Bronze Sponsor
Driving Innovation in Process Analytics.
Precision is more than a promise, it is engineered into every sensor we build.
Designed for bioprocesses in biopharma and various processes in other industries, our in-line process analytics sensor solutions offer real-time measurement of critical process parameters and key performance indicators. Additionally, intuitive tools like our ArcAir simplify management of process sensors and ensure GMP compliance. All Hamilton sensor solutions are backed by our world-class customer service, support, on-site assistance, and training.
Miltenyi Biotec
Bronze Sponsor
Miltenyi Biotec is a global leader in innovating technologies and services for patient-specific cell and gene therapies, turning scientific discoveries into practical treatments for personalized medicine. Having pioneered a groundbreaking method of cell separation, Miltenyi Biotec continues to set industry standards today. With over 35 years of expertise, it supports customers in biomedical discoveries, translating them into clinical applications to enable access to new therapies for patients. Miltenyi Biotec focuses on providing integrated, advanced solutions to address complex challenges in the treatment of cancers, autoimmune diseases, and inherited disorders. Through its Miltenyi Bioindustry division, it provides expert guidance to therapy developers, helping them efficiently and cost-effectively navigate the path from process development to commercialization. Miltenyi Biotec is headquartered in Bergisch Gladbach and has a global team of 4,700 employees across 24 countries.
Novo Nordisk Pharmatech
Bronze Sponsor
At Novo Nordisk Pharmatech, we are committed to developing life science solutions that enable medicines for our customers sustainably. We are proud that our innovative research and products help millions of people around the world live better lives.
We provide products to aid pharmaceutical manufacturing in four product areas: Recombinant Insulin, Enzymes, Resins, and Benzalkonium Chloride.
We will continue strengthening our partnerships with those customers needing animal-free and reliable ingredients supplied securely and consistently.
Quality is our top priority, and we always ensure high batch-to-batch consistency across our products according to regulations, with cGMP being a key capability.
We’re a company of dedicated enablers who carry over 75 years of finely calibrated knowledge and expertise across the entire value chain. By embracing trial and error as the fastest way to get to success, we enable better life-science innovation for industries and institutions across the world.
PHC Europe B.V.
Bronze Sponsor
As part of the PHC Group rooted in Japan, we are among the world’s leading producers and suppliers of high-quality, high-precision laboratory instruments. Our mission is to advance life sciences through reliable and innovative technologies.
All our products are developed and manufactured with in-house Japanese craftsmanship and are widely used by researchers and professionals in the pharmaceutical, biotechnology, and healthcare sectors.
Within our division, we operate across two key business fields — Biomedical and Diagnostics — serving a broad and growing range of life science facilities. Our cell analysis portfolio includes the Live Cell Metabolic Analyzer (LiCellMo), Live Cell Imaging System for 2D and 3D cultures, and the LiCellGrow bioprocessing system, powered by real-time cellular measurement.
Together with scientists worldwide, we are committed to driving life science innovation through precision, quality, and trust.
Scientific Bioprocessing
Bronze Sponsor
Scientific Bioprocessing, Inc. (sbi) is dedicated to offering cutting-edge solutions for the life science industry, pioneering digitally simplified bioprocessing. sbi's DOTS Platform provides a broad portfolio of state-of-the-art bioprocessing sensors (for e.g., biomass, pH, or dissolved oxygen) and actuators, as well as the innovative DOTS Software for easy sensor control and data monitoring. With this equipment, sbi's customers can monitor critical parameters in real-time, optimizing their bioprocesses and achieving higher product yields. sbi is committed to delivering exceptional customer service. The company is a subsidiary of Scientific Industries Inc.
Network & Programme Sponsors
Abselion
Network & Programme Sponsor
Abselion develops practical measurement tools that simplify complex biological workflows and deliver reliable, actionable data.
We create solutions that bring together robust engineering, purpose-built assay formats, and intuitive software. Our approach enables faster, more confident decisions in life sciences, biotechnology, and therapeutic development without the cost or complexity of traditional systems.
Founded as a spin-out from the University of Cambridge, Abselion was created to make scientific measurement both precise and practical. We continue to expand our capabilities to meet evolving research needs, delivering tools that are dependable, easy to use, and built for the pace of today’s research.
.png?length=600&name=3830b472-0334-4c66-ad83-e473b1eba604-2-5668375logo-Azenta_Logo_Primary_FullColor_BlackType_RGB-(4).png){kind=logo}
Azenta Life Sciences
Network & Programme Sponsor
Azenta Life Sciences is a global leader in cryogenic storage and sample management, supporting the unique needs of cell and gene therapy innovators. Our state-of-the-art biorepositories and automated storage systems are designed to safeguard the integrity, quality, and traceability of critical samples at every stage of development. With industry-leading expertise in cryogenic cold chain solutions, we help organizations minimize risk, maintain compliance, and ensure that irreplaceable materials are securely preserved and always accessible. By delivering scalable and reliable solutions, Azenta empowers researchers and developers to focus on advancing groundbreaking therapies and accelerating their path to patients.
Benchling
Network & Programme Sponsor
Benchling is the pioneer of the R&D Cloud, software that powers the biotechnology industry. It gives scientists a central source of truth for R&D data. With Benchling, scientists can accelerate R&D and bring life-changing medicines and products to people faster. More than 200,000 scientists at over 1,300 companies and 7,500 academic and research institutions globally rely on Benchling to convert the complexity of biology into world-changing results. For more, please visit Benchling.com.
Bio-Techne
Network & Programme Sponsor
Bio-Techne empowers scientists and clinicians by providing high-quality reagents, analytical instruments, and precision diagnostics. Whether you’re at the cutting edge of academic research, translating discoveries to therapeutic leads, or requiring the highest level of diagnostic testing, you’ll find products and services that help lead you to better answers.
Biocair
Network & Programme Sponsor
Since 1986, Biocair has established a global reputation as a leading GDP logistics specialist within the pharmaceutical, biotechnology and life sciences sectors.
Biocair has built up a unique, client-centric approach by employing scientists in front-line logistics positions and assembling a team of best-in-class industry experts in quality, cold chain and regulatory compliance.
Biocair employs 475 people worldwide and provides specialist logistics services to more than 160 countries through a global network of partners. Biocair’s offices are located in the UK, France, Belgium, Germany, USA, South Africa, China and India.
For further information on Biocair, please visit www.biocair.com.
CellVoyant Technology Ltd
Network & Programme Sponsor
CellVoyant is a biotechnology company that predicts stem cell differentiation using live cell microscopy and artificial intelligence. We use this approach to optimise and unlock human cell manufacturing for research and therapeutics applications. We aim to understand and solve important health issues, make a long-lasting positive impact on society and change the world.
At the heart of CellVoyant is FateView, our AI-powered SaaS platform. FateView enables biologists to visualise, track, and forecast cell differentiation in real-time. It supports high-throughput experimentation and model inference, combining microscopy, computer vision, cloud infrastructure, and AI to serve cutting-edge stem cell research and manufacturing.
Cytena
Network & Programme Sponsor
We’re on a mission to build the future of health
Based in Freiburg, Germany, CYTENA aims to provide the finest life science technologies to researchers and lab technicians around the world. We combine advanced automation, state-of-the-art software engineering and the latest insights in molecular biology to create systems that simplify complex lab workflows, all while making these processes more efficient and affordable.
Since 2014, we have developed strong relationships with some of the world’s most prestigious pharmaceutical companies. Our technology provides solutions for a wide range of application areas including stable cell line development (CLD), single-cell omics, high-throughput screening and drug discovery.
In addition to our cutting-edge technologies, CYTENA aims to provide exceptional customer service and user-friendly designs to foster accessibility, collaboration and progress in the lab. As a part of BICO, the world’s leading bioconvergence company, we strive to create the future of health.
Cytomos
Network & Programme Sponsor
Cytomos is a purpose and impact driven organisation that is seeks to utilises the label free analytical technology dielectric spectroscopy to address the major challenges facing cell line development and cell therapy manufacturing.
Cytomos' flagship instrument, Celledonia™, was developed by an in-house team of Biologists and Engineers. This technology has now been used in a number of proof-of-concept studies in partnership with biotech and pharma companies who see the value in this novel technology.
EnzyScreen BV
Network & Programme Sponsor
Enzyscreen is a supplier of laboratory equipment and is specialised in shaken cultivations in microtiter plates. We sell high quality microtiter plates for different working volumes and also closure systems for these microtiter plates. Our aim is that our customers have successful and reproducible scale down experiments. This year we are bringing our special microtiter plates with breathable lids and our automated incubator shaker.
Getinge
Network & Programme Sponsor
At Getinge, we are committed to meet today's health care challenges together with health care providers and be part of improving patients’ lives around the globe. Our offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Our journey started in the village of Getinge on the Swedish west coast back in 1904. Today, our operations cover more than 40 countries and we over 10 000 employees. Every single one of us with the firm belief that saving lives is the best job in the world. Learn more about us: https://youtu.be/4FB5vGF78CY
Gyros Protein Technologies
Network & Programme Sponsor
Gyros Protein Technologies provides enabling peptide synthesis and bioanalytical solutions helping scientists increase biomolecule performance and productivity in pre-clinical/clinical development and bioprocess applications. The automated Gyrolab® immunoassay platforms and expanding portfolio of kits are used by scientists in leading pharmaceutical, biotech and CRO/CMO companies in the development and manufacturing of biotherapies including cell and gene therapies. Gyrolab immunoassays provide key workflow advantages of speed, automation, and low sample and reagent usage with a wide dynamic range in applications including PK/PD, immunogenicity, titer determination, and analysis of bioprocess-related impurities
Haier Biomedical UK
Network & Programme Sponsor
Haier Biomedical is a global leader in life science and medical innovation, delivering intelligent, sustainable solutions that safeguard samples, protect patients, and empower discovery. With a UK Centre of Excellence and NHS Supply Chain approval, we combine international innovation with local expertise to support clinical, research, and advanced therapy environments.
Our portfolio continues to expand, covering ultra-low temperature and cryogenic freezers, blood and pharmacy storage, biological safety cabinets, centrifuges, incubators, and wireless monitoring platforms. By offering dependable, compliant technologies, we support laboratories at every stage of their journey—from early research through to large-scale operations.
Increasingly, we are working closely with our partners in cell and gene therapy to co-develop the next generation of laboratory infrastructure. From automated cell culture systems and automated biobanking to integrated digital monitoring platforms, our focus is on enabling reproducible, scalable, compliant and sustainable workflows that meet the unique challenges of advanced therapies.
At Haier Biomedical, we don’t just supply equipment—we collaborate to solve problems, deliver value, and shape the future of laboratory practice. By combining agility, global R&D strength, and a consultative approach, we are uniquely positioned to support our customers’ progress across the fast-evolving cell and gene therapy landscape.
Visit us at Cell 2025 to explore how Haier Biomedical is supporting the laboratories of today while helping build the therapies of tomorrow.
IotaSciences
Network & Programme Sponsor
iotaSciences offers efficient automation solutions for gentle single-cell isolation and cloning, as well as expert cell-line engineering services focused on human induced pluripotent stem cells. Our modular systems support researchers in increasing the speed and efficiency of their research, opening new frontiers and helping advance the therapies of the future.
PhoenixBio USA Corporation
Network & Programme Sponsor
PhoenixBio is a global leader in the development and distribution of high-quality human liver models. Our PXB-Mouse® is a humanized liver animal model and has a liver repopulated with up to 98% human hepatocytes. PXB-cells® are human hepatocytes freshly isolated from the
PXB-mouse and are frequently applied for in vitro research.
PhoenixBio models accelerate pharmaceutical and chemical compound development due to their unique ability to deliver preclinical insights that are more predictive of human outcomes. Our models are applied in several research areas, including viral hepatitis (HCV, HBV, HBV/HDV),
MASH/MAFLD, Gene Therapy & Editing, DMPK/Toxicology, and more!
PL-Biosciences
Network & Programme Sponsor
Located in Aachen in Germany, PL BioScience GmbH is a life science company specializing in the production and development of Human Platelet Lysate (HPL), offering a complete portfolio of HPL products tailored for various use cases;from standard laboratory research to GMP compliant cell therapies.
PL BioScience was founded in 2015 as an RWTH Aachen University spin-off. Since then, they have been exploring the broad potential of human platelets with a mission is to enhance advances in cellular research and therapy with one forward-looking Technology: ELAREM™. The high growth factor content of HPL combined with its animal-free origin not only supports optimal cell growth, but also enables it’s use in various applications.
From academic research, pre-clinical research, to cellular therapy, the high quality GMP compliant standards of ELAREM™ ensures seamless transitions of regenerative medicine breakthroughs – from the lab to patients in need.
Contact:
PL BioScience GmbH
Auf der Hüls 184–186
52068 Aachen, Germany
Dr. Hatim Hemeda – CEO & Founder
Christian Wilkes – CFO & Founder
Phone: +49 (0) 241 / 957 19 - 100
E-mail: info@pl-bioscience.com
Website: https://www.pl-bioscience.com/
Promocell
Network & Programme Sponsor
At PromoCell, we empower scientists worldwide with high-quality human cell culture products to advance research from discovery to clinical applications. Our portfolio includes human primary cells, stem cells, blood cells, and optimized media, supported by expert guidance at every stage of the research journey.
With over 35 years of experience, we’re a trusted partner in life sciences, helping researchers overcome challenges in cell therapy and regenerative medicine. Thus, we also offer Excipient GMP-grade cell culture media manufacturing, tailored for research institutions and red biotechnology innovators. This ensures a straightforward path towards clinical applications, backed by step-by-step support and quality.
We go the extra mile because we believe in the work scientists do. Our philosophy, Human Centered Science, reflects our commitment to providing not just products, but partnership delivered by experts.
Roche Diagnostics Deutschland GmbH
Network & Programme Sponsor
Roche CustomBiotech - your strategic partner at every step of biomanufacturing:
As part of the global biotechnology company Roche we are a leading supplier of innovative, high-quality raw materials, instruments and kits to forward-thinking biopharma and diagnostics businesses.
By utilizing precisely defined and scalable raw materials, coupled with robust quality Roche CustomBiotech is your dedicated partner in manufacturing cell and gene therapies.
Located in our state-of-the-art biotechnology facility in Penzberg, Germany, we combine the expertise of pharma and diagnostics with decades of experience in producing high-quality raw materials.
Discover our portfolio for Cell and Gene therapy manufacturers.
RoslinCT
Network & Programme Sponsor
RoslinCT is a leading global contract development and manufacturing services organization (CDMO) focused on Advanced Cell and Gene Therapies. Established in 2006 and built upon the ground-breaking technology cloning of Dolly the Sheep at the Roslin Institute in 1997, RoslinCT has harnessed cutting-edge science to advance the development of human medicines. With a remarkable heritage in the field, the company has achieved significant milestones. These include being among one of the first in the world to produce clinical-grade human pluripotent stem cells. In collaboration with the partners, RoslinCT also developed the first CRISPR-edited cell therapy product for a major inherited disorder, taking it from early development to commercialization.
Equipped with 22 purpose-built cGMP cell therapy processing suites in Edinburgh, Scotland, and Hopkinton, Massachusetts, RoslinCT provides innovative process and analytical development, cGMP clinical and commercial manufacturing for a range of cell types for both autologous and allogeneic processes, and cGMP iPSC cell line development, gene editing, and differentiation.
With tailored CDMO solutions, RoslinCT enables partners to efficiently progress from development to commercialisation and deliver life-saving Cell and Gene Therapies worldwide. RoslinCT is a GHO Capital portfolio company. Discover more about our services at www.roslinct.com.
Sartorius BIA Separations
Network & Programme Sponsor
Sartorius BIA Separations develops and manufactures market-leading CIM® monolithic chromatographic columns for the purification and analysis of large biomolecules, such as viruses, plasmids, and mRNA, which are applied in cell and gene therapies. The company’s Cornerstone® Biomanufacturing Development Services are the result of more than 25 years of hands-on experience with the most challenging biopharmaceutical products and offer a comprehensive approach of integrated process development solutions and novel technology designed to improve the robustness and yield of large biomolecules production while improving the safety of therapeutic products. Sartorius BIA's technology for manufacturing-scale purification is already used in the production of the first commercialized advanced therapeutics;the company also has a keen presence with novel drug candidates in the clinical pipeline.
SGS Vitrology
Network & Programme Sponsor
SGS is the world’s leading inspection, verification, testing and certification company. With more than 90,000 employees, SGS operates a network of over 1,500 offices and laboratories around the world.
The Life Science division serves pharmaceutical, biopharmaceutical, and medical device companies along the entire drug development pathway. With over 35 years’ experience as a global contract service organization, SGS provides integrated (bio)pharmaceutical development and testing solutions including clinical research, pharmaceutical development, biologics characterization, biosafety, and quality control testing for small and large molecules, raw materials, containers and finished products.
SGS Vitrology provides a comprehensive range of biosafety services such as: virology, cell and molecular biology as well as microbiology and electron microscopy. Health Authorities, including the US FDA and the EMA, require companies to undergo safety testing demonstrating that cell banks, viral banks, raw materials, bulk harvests, and batches of clinical drug are free of bacteria, fungi, mycoplasma, viruses, and other potential contaminants. SGS Vitrology helps clients by ensuring product safety in satisfying these regulatory requirements. Our GLP/GMP facility is MHRA certified, and US FDA audited.
W. L. Gore & Associates
Network & Programme Sponsor
W. L. Gore & Associates is a global materials science company dedicated to transforming industries and improving lives. Since 1958, Gore has solved complex technical challenges in demanding environments — from outer space to the world’s highest peaks to the inner workings of the human body. With more than 12,000 Associates and a strong, team-oriented culture, Gore generates annual revenues of $4.5 billion.
Start-Ups
Avigen
Start Up Zone
Avigen is a preclinical Contract Research Organisation dedicated to accelerating the development of cell-based immunotherapies for cancer by measuring cellular avidity, the binding strength between immune and cancer cells. The company’s proprietary platform enables high-throughput testing, sorting, and isolation of immune cells, allowing the rapid identification of therapeutic leads from millions of candidates.
Avigen’s services support the discovery, optimisation, and translation of immunotherapies with reduced risk and shorter development timelines. The company partners with biotechnology and pharmaceutical organisations across multiple modalities, including but not limited to CAR-T, TCR-T, NK, CAR-NK, and cell engager therapies.
Avigen equips cell therapy innovators with fundamental, actionable insights that enable the rapid development of safe and effective cancer treatments.
Green Elephant Biotech
Start Up Zone
Green Elephant Biotech is revolutionizing the field of biopharmaceutical manufacturing by addressing one of its greatest challenges: the production bottleneck for adherent cells. Founded in 2021 by Joel Eichmann and Felix Wollenhaupt, the company leverages cutting-edge technology with a focus on sustainable and scalable solutions to increase the accessibility and affordability of life-saving therapies.
Their flagship product is a novel cell expansion system designed to enhance production capacity for adherent cells. By significantly improving efficiency, CellScrew® helps overcome the industry's constraints, enabling scalable, automatable, and more economical manufacturing of biopharmaceuticals. This advancement is pivotal for expanding patient access to critical treatments, from cell and gene therapies to vaccines.
An innovative design, coupled with the use of plant-based polymer polylactic acid (PLA), significantly reduces waste and lowers the carbon footprint of the biopharmaceutical industry. By prioritizing the planet alongside patient needs, the company exemplifies how biotechnology can align with global sustainability goals.
Green Elephant recently introduced three versions of 96-well plates made from polylactic acid (PLA), expanding their portfolio for a more sustainable industry.
For more information, visit www.greenelephantbiotech.com
Quickr
Start Up Zone
QUiCKR Bio accelerates R&D for Cell and Gene Therapies. QUiCKR’s kits and software allow QC of editing outcomes in 20 min for a third of NGS costs. QUiCKR’s fast assay speeds-up iterations on safety and efficacy testing, IND-enabling studies, and process development.
The fluorescence-based assay runs on standard plate readers or thermocyclers, with no new instrument required. Fluorescence data is then instantly processed through QUiCKR’s cloud platform. QUiCKR achieves 300 samples/hour with NGS-level accuracy and 15 min hands-on time. Speed is achieved with preplated, preQC-ed and customized reagents, that are ready to run out of the box. Visit quickrbio.com to learn more.
Looking forward to sharing our newest data at Cell 2025.
Radix Partners
Start Up Zone
Radix Partners was founded with the mission to bridge the gap between scientific innovation with operational planning and execution in advanced therapies. We provide specialised consultancy services across strategy, tactics, and execution to optimise and evolve your operational value chain processes. From early clinical stages to global commercial models, we unlock the full value chain of your operations. Our diverse and specialised set of skills alongside our combined industry experience in clinical and commercial operations are a key differentiator. In-house, we have direct cross-functional expertise—spanning supply chain, manufacturing, commercial readiness, and CGT economics —to help biotech companies and solution providers realise their clinical and commercial ambitions. Our approach is to partner deeply, not just as consultants, but as thought partners helping to build durable operating models matching the industry operational complexity. Radix itself, as a word, in Latin, means “Root”, “Foundation”. As enablers of growth, we help our clients establish strong operational roots and long term sustainable commercial success. If your science is cutting edge, your operations should be too! Build your operations strategy as early as your science. Please visit www.radix.partners for our full services offering.
